USPTO Examiner SIPPEL RACHEL T - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19037930BUTTON ASSEMBLY FOR INHALER, AND INHALERJanuary 2025May 2025Allow300YesNo
19025842TRIGGER ASSEMBLY FOR INHALER, AND INHALERJanuary 2025April 2025Allow300YesNo
19025711TRIGGER ASSEMBLY FOR INHALER, AND INHALERJanuary 2025April 2025Allow300YesNo
18932726DUST MITIGATION HEADGEAROctober 2024December 2024Allow100YesNo
18913327Maskless Respiratory and Eye Protection Device for Aerosols and Vapors including Chemical, Biological, Radiological, and Nuclear (CBRN) ContaminantsOctober 2024April 2025Allow621YesNo
18667675Receptacle DeviceMay 2024January 2025Allow811YesNo
18643951THERAPEUTIC DEVICE FOR TREATMENT OF HEADACHE AND PAINApril 2024June 2025Allow1410YesNo
18597602SMART OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICEMarch 2024September 2024Allow700YesNo
18682259CANNULA HOLDERFebruary 2024April 2025Abandon1420YesNo
18410485COMPRESSION GARMENT APPARATUSJanuary 2024April 2025Allow1510YesNo
18527858SELF-SANITIZING RESPIRATORY ASSEMBLY AND METHODS OF MAKING AND USING THE SAMEDecember 2023May 2025Allow1730YesNo
18466435HEADGEAR ASSEMBLY FOR BREATHING INTERFACESeptember 2023February 2025Allow1720YesNo
18234976MEIBOMIAN GLAND ROLLERAugust 2023June 2025Allow2230YesNo
18450030DRY POWDER MEDICAMENT INHALERAugust 2023July 2024Allow1101YesNo
18223475Heating UnitsJuly 2023April 2025Abandon2111NoNo
18352146PRESSURE ADJUSTMENT METHOD FOR CPAP MACHINEJuly 2023June 2025Abandon2330NoNo
18349018SYSTEMS AND METHODS FOR MEDICAL DIAGNOSTICS AND MEDICATION DELIVERYJuly 2023October 2024Abandon1510NoNo
18328016UNITARY RESPIRATOR WITH MOLDED THERMOSET ELASTOMERIC ELEMENTSJune 2023April 2024Allow1110NoNo
18138410SMART OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICEApril 2023December 2023Allow800YesNo
18028450PERSONAL PROTECTION SYSTEM AND METHODMarch 2023March 2025Allow2430YesNo
18124486APPARATUS WITH FASTENERLESS CONNECTION BETWEEN COMPONENTS AND ASSEMBLY METHOD THEREOFMarch 2023April 2024Abandon1310NoNo
18186814Wearable Active-Compression Therapy and TreatmentMarch 2023January 2024Abandon1010NoNo
18109326NASAL DELIVERY DEVICESFebruary 2023March 2024Allow1321YesNo
18109727Nose MaskFebruary 2023October 2023Allow810YesNo
18107667MACHINE PROXIMATE NEBULIZERFebruary 2023March 2025Allow2521YesNo
17968921DRY POWDER MEDICAMENT INHALEROctober 2022February 2025Allow2801YesNo
17968555DRY POWDER MEDICAMENT INHALEROctober 2022May 2023Allow701YesNo
17952139AMBULATORY DISINFECTION WITH NEAR FIELD FAR UV-C OR OTHER SAFE ANTIMICROBIAL LIGHT WAVES FOR HUMAN OR VETERINARY ANIMATE/INANIMATE PERSONAL AND PUBLIC SURFACES AND SPACES ESPECIALLY MEDICAL PPES, APPARATUSSeptember 2022September 2023Abandon1111NoNo
17912909FOLDABLE INHALERSeptember 2022June 2025Allow3300YesNo
17893147NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREINAugust 2022April 2024Abandon2010NoNo
17888699INHALERAugust 2022February 2024Allow1820YesNo
17887551Micro bi-Directional Valves and SystemsAugust 2022September 2023Abandon1310NoNo
17882984COMPRESSION GARMENT APPARATUSAugust 2022October 2023Allow1400YesNo
17874531PRESERVATIVE-FREE SINGLE DOSE INHALER SYSTEMSJuly 2022July 2023Allow1210YesNo
17874178AMBULATORY DISINFECTION WITH NEAR FIELD FAR UV-C OR OTHER SAFE ANTIMICROBIAL LIGHT WAVES FOR HUMAN OR VETERINARY ANIMATE/INANIMATE PERSONAL AND PUBLIC SURFACES AND SPACES ESPECIALLY MEDICAL PPES, APPARATUSJuly 2022August 2023Abandon1311NoNo
17869318OXYGEN GENERATOR FOR USE IN AN AIRCRAFT, PASSENGER OXYGEN MASK SYSTEM, AND AIRCRAFTJuly 2022May 2025Allow3400YesNo
17852962DEVICE, SYSTEM, AND/OR METHOD FOR TREATING AND MONITORING A PATIENTJune 2022May 2024Abandon2340YesNo
17808955Responsive Whole Patient Care Compression Therapy and Treatment SystemJune 2022December 2022Allow600NoNo
17808958BREATHING ASSISTANCE APPARATUSJune 2022February 2023Allow710YesNo
17846229ANESTHETIC DISPENSER WITH MIXING UNIT AND ANESTHETIC TANK AND PROCESS USING ANESTHETIC DISPENSERJune 2022March 2025Allow3300YesNo
17787494Mouth protection device for a respiratory protection systemJune 2022January 2023Allow700YesNo
17834298FACE MASKJune 2022May 2025Abandon3610NoNo
17826142QUICK-RELEASE NEBULIZERMay 2022February 2025Allow3300NoNo
17774219DOUBLE ACTIVATION PREVENTIONMay 2022March 2025Allow3500YesNo
17731902SYSTEMS AND METHODS FOR MEDICAL DIAGNOSTICS AND MEDICATION DELIVERYApril 2022July 2023Abandon1510NoNo
17726948MASK FOR PREVENTING WATER FROM ENTERING TRACHEAL STOMAApril 2022November 2024Allow3100NoNo
17659247AIR DELIVERY SYSTEM HAVING DUAL CONFIGURATION AIR FILTRATION ASSEMBLYApril 2022March 2025Allow3500YesNo
17717628FACE MASK SECURING DEVICEApril 2022May 2025Abandon3710NoNo
17698997MASK WITH ANTI-FOGGING CONSTRUCTIONMarch 2022September 2022Allow610YesNo
17683502AUTOMATED SELF-CONTAINED HOOKAH SYSTEM WITH UNOBSTRUSIVE AQUATIC DATA RECORDINGMarch 2022April 2024Abandon2620YesNo
17674198INTELLIGENT GAS SOURCE MANAGEMENTFebruary 2022May 2025Allow3920YesNo
17648547AIR PURIFIER AND FILTER ASSEMBLY THEREOFJanuary 2022April 2025Abandon3810NoNo
17572939Wearable Active-Compression Therapy and TreatmentJanuary 2022December 2022Allow1100YesNo
17570639INSTALLATION FOR SUPPLYING THERAPEUTIC GAS TO A PATIENT WHILE TAKING ACCOUNT OF THE LOSSES OF LEAKTIGHTNESS AT THE MASKJanuary 2022February 2025Allow3710YesNo
17625335FACE MASKJanuary 2022January 2023Allow1210YesNo
17567715Tracheal Introducer SheathJanuary 2022September 2024Abandon3340YesNo
17564871Receptacle DeviceDecember 2021January 2024Allow2561YesNo
17564321HUMIDIFIER RESERVOIRDecember 2021July 2023Allow1900YesNo
17561934AIR SUPPLY MECHANISM WITH LOWER AIR DUCT, HEADGEAR AND ELECTRIC PROTECTIVE EQUIPMENTDecember 2021May 2023Allow1700YesNo
17645019FACE MASKDecember 2021September 2022Abandon910NoNo
17554124BREATHABLE GAS SUPPLY APPARATUSDecember 2021June 2022Allow610YesNo
17619833MEDICAL VEST AND USING METHOD THEREOFDecember 2021April 2025Allow4020YesNo
17596454Tremor Stabilisation ApparatusDecember 2021May 2025Allow4101YesNo
17545920SYSTEM AND METHOD FOR PERFORMING TISSUE TREATMENT USING POWERED TREATMENT DEVICESDecember 2021December 2024Allow3610YesNo
17643266BREATHING ASSISTANCE APPARATUSDecember 2021December 2023Abandon2420NoNo
17541658FACEPIECE RESPIRATORDecember 2021May 2025Abandon4211NoNo
17528916ENDOTRACHEAL TUBE FASTENING APPARATUS AND USE THEREOFNovember 2021June 2023Abandon1940YesNo
17526688REUSABLE FILTERING FACE MASKNovember 2021June 2025Allow4310YesNo
17508666TRACKING OF CARDIAC RESUSCITATION PROCEDURE AND TRANSITIONS OF CAREOctober 2021November 2024Allow3710YesNo
17505931MULTIFUNCTIONAL VENTILATOR INTERFACESOctober 2021June 2024Allow3200YesNo
17601643DOUBLE-LAYER LIGHT-TRANSMISSIVE FACE MASKOctober 2021April 2022Allow600YesNo
17484326WRAP-BACK HEADGEAR FOR PATIENT INTERFACESeptember 2021September 2024Allow3610YesNo
17478961ULTRASONIC ELECTRONIC RHINITIS THERAPEUTIC APPARATUS WITH FAR-INFRARED ATOMIZED COCONUT ESSENTIAL OILSeptember 2021May 2024Allow3200YesNo
17472501MASK WITH ADJUSTABLE EAR LOOPS AND MANUFACTURING METHOD THEREOFSeptember 2021November 2024Abandon3901NoNo
17466004ADVANCED SYSTEM AND METHOD FOR A DEEP TISSUE MASSAGERSeptember 2021July 2024Allow3410YesNo
17461796MEIBOMIAN GLAND ROLLERAugust 2021October 2022Allow1300YesNo
17460222SPEAKING ENDOTRACHEAL TUBE AND METHOD OF USEAugust 2021January 2022Allow400YesNo
17407503EXTERNAL EAR CANAL PRESSURE REGULATION SYSTEMAugust 2021May 2025Allow4530YesNo
17401733EXTERNAL EAR CANAL PRESSURE REGULATION DEVICEAugust 2021May 2025Allow4510NoNo
17379054PAPR FrameJuly 2021October 2021Allow300YesNo
17422797DRY POWDER INHALER DEVICEJuly 2021April 2024Allow3300YesNo
17305260NASAL DELIVERY DEVICESJuly 2021November 2022Allow1701YesNo
17305198PRESSURE ADJUSTMENT METHOD FOR CPAP MACHINEJuly 2021April 2023Allow2110YesNo
17352226FILTER MASK WITH ACCESSORY BELTJune 2021August 2022Abandon1420YesNo
17349465FACIAL COVERING SYSTEMJune 2021September 2022Allow1520YesNo
17342223CONNECTOR FOR MEDICATION DISPENSERJune 2021October 2024Abandon4010NoNo
17341311NITRIC OXIDE GENERATION, DELIVERY, AND MONITORING SYSTEMJune 2021July 2024Allow3710YesNo
17339423DOUBLE-PROTECTION MEDICAL MASK, PREFERABLY FOR FILTERING DUST, SMOG, AEROSOL, PATHOGENIC AGENTS, VIRUSES AND THE LIKEJune 2021July 2024Abandon3710NoNo
17335421APPLICATOR FOR TRACHEOSTOMA BASEPLATEJune 2021September 2024Abandon3910NoNo
17333307DRY POWDER INHALERMay 2021December 2022Allow1900YesNo
17303459DEVICES FOR PREVENTING INHALATION OF, EXPOSURE TO, AIRBORNE MATERIALMay 2021March 2025Allow4520YesNo
17318393BREATHABLE GAS APPARATUS WITH HUMIDIFIERMay 2021September 2021Allow400YesNo
17315236METHOD AND DEVICE FOR BREATHING RECOGNITION, VENTILATION APPARATUS, AND STORAGE MEDIUMMay 2021June 2025Allow4920YesNo
17313182FACE MASK WITH FILTERMay 2021May 2024Abandon3610NoNo
16958834DEVICE FOR AIDING PLANTAR FLEXOR MUSCLESMay 2021January 2025Abandon5510NoNo
17223724WEARABLE FACE MASK WITH ANTI-VIRAL FILTRATION MEDIAApril 2021June 2025Abandon5140NoNo
17220881BLOWER FOR RESPIRATOR DEVICEApril 2021March 2025Allow4811YesNo
17215779PORTABLE APPARATUS FOR PROVIDING CHEST THERAPYMarch 2021May 2024Allow3710YesNo
17280195METHOD AND DEVICE FOR MONITORING DRUG INTAKEMarch 2021April 2024Allow3710NoNo
17207328PERSONAL PROTECTIVE EQUIPMENT AND METHODS FOR PREVENTING SPREAD OF INFECTIOUS DISEASEMarch 2021December 2024Abandon4511NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SIPPEL, RACHEL T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
15
Examiner Affirmed
14
(93.3%)
Examiner Reversed
1
(6.7%)
Reversal Percentile
20.7%
Lower than average

What This Means

With a 6.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
23
Allowed After Appeal Filing
3
(13.0%)
Not Allowed After Appeal Filing
20
(87.0%)
Filing Benefit Percentile
13.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 13.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SIPPEL, RACHEL T - Prosecution Strategy Guide

Executive Summary

Examiner SIPPEL, RACHEL T works in Art Unit 3785 and has examined 383 patent applications in our dataset. With an allowance rate of 64.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner SIPPEL, RACHEL T's allowance rate of 64.2% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SIPPEL, RACHEL T receive 1.99 office actions before reaching final disposition. This places the examiner in the 65% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SIPPEL, RACHEL T is 37 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +62.9% benefit to allowance rate for applications examined by SIPPEL, RACHEL T. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.5% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.1% of cases where such amendments are filed. This entry rate is in the 14% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 44.4% of appeals filed. This is in the 7% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 42.0% are granted (fully or in part). This grant rate is in the 43% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 53% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.8% of allowed cases (in the 54% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.